Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 3
1955 1
1957 2
1958 3
1959 2
1962 2
1965 1
1966 1
1967 1
1968 3
1969 1
1970 1
1971 1
1972 4
1973 3
1974 7
1975 2
1976 2
1977 6
1978 2
1979 5
1980 5
1981 11
1982 13
1983 9
1984 7
1985 3
1986 6
1987 3
1988 8
1989 5
1990 6
1991 7
1992 3
1993 9
1994 4
1995 8
1996 6
1997 7
1998 12
1999 9
2000 13
2001 16
2002 23
2003 26
2004 23
2005 32
2006 34
2007 25
2008 30
2009 17
2010 32
2011 36
2012 38
2013 38
2014 36
2015 41
2016 33
2017 26
2018 39
2019 36
2020 40
2021 49
2022 33
2023 24
2024 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

877 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for reinhardt d[Author]
Your search for Rheinhardt D[Author] retrieved no results
Otitis media: Antibiotika oder Röhrchen?
Reinhardt D. Reinhardt D. MMW Fortschr Med. 2022 May;164(9):26. doi: 10.1007/s15006-022-1153-z. MMW Fortschr Med. 2022. PMID: 35513651 Review. German. No abstract available.
ICS/LABA für ehemalige Frühgeborene?
Reinhardt D. Reinhardt D. MMW Fortschr Med. 2022 Feb;164(3):31. doi: 10.1007/s15006-022-0801-7. MMW Fortschr Med. 2022. PMID: 35146664 Review. German. No abstract available.
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP. Ripperger T, et al. Among authors: reinhardt d. Am J Med Genet A. 2017 Apr;173(4):1017-1037. doi: 10.1002/ajmg.a.38142. Epub 2017 Feb 7. Am J Med Genet A. 2017. PMID: 28168833 Review.
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.
Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz SC, Sendker S, Bartels N, Thomitzek A, Smorra D, Hejazi M, Uhrberg M, Scheckenbach K, Monzel C, Wiek C, Reinhardt D, Niktoreh N, Hanenberg H. Soldierer M, et al. Among authors: reinhardt d. Front Immunol. 2022 Apr 7;13:847008. doi: 10.3389/fimmu.2022.847008. eCollection 2022. Front Immunol. 2022. PMID: 35464442 Free PMC article.
Bilinguale Kinder lernen verzögert sprechen.
Reinhardt D. Reinhardt D. MMW Fortschr Med. 2017 Oct;159(17):42. doi: 10.1007/s15006-017-0122-y. MMW Fortschr Med. 2017. PMID: 28994072 German. No abstract available.
Fibrillin-1 regulates endothelial sprouting during angiogenesis.
Alonso F, Dong Y, Li L, Jahjah T, Dupuy JW, Fremaux I, Reinhardt DP, Génot E. Alonso F, et al. Among authors: reinhardt dp. Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2221742120. doi: 10.1073/pnas.2221742120. Epub 2023 May 30. Proc Natl Acad Sci U S A. 2023. PMID: 37252964 Free PMC article.
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.
Pennesi E, Michels N, Brivio E, van der Velden VHJ, Jiang Y, Thano A, Ammerlaan AJC, Boer JM, Beverloo HB, Sleight B, Chen Y, Vormoor-Bürger B, Rives S, Bielorai B, Rössig C, Petit A, Rizzari C, Engstler G, Starý J, Bautista Sirvent FJ, Chen-Santel C, Bruno B, Bertrand Y, Rialland F, Plat G, Reinhardt D, Vinti L, Von Stackelberg A, Locatelli F, Zwaan CM. Pennesi E, et al. Among authors: reinhardt d. Leukemia. 2022 Jun;36(6):1516-1524. doi: 10.1038/s41375-022-01576-3. Epub 2022 Apr 25. Leukemia. 2022. PMID: 35468945 Free PMC article. Clinical Trial.
Nur Mini-Vorteil für ICS-Therapie bei Covid.
Reinhardt D. Reinhardt D. MMW Fortschr Med. 2022 Jul;164(13):26. doi: 10.1007/s15006-022-1282-4. MMW Fortschr Med. 2022. PMID: 35817906 Free PMC article. Review. German. No abstract available.
877 results